middle.news
How Nexsen’s Rapid GBS Sensor Could Transform Maternal Health Diagnostics
9:29am on Tuesday 6th of January, 2026 AEDT
•
Healthcare
Read Story
How Nexsen’s Rapid GBS Sensor Could Transform Maternal Health Diagnostics
9:29am on Tuesday 6th of January, 2026 AEDT
Key Points
FDA pre-submission lodged early for GBS rapid sensor under 510(k) pathway
FDA feedback expected within 70 days to guide formal submission
Appointment of Richard Jarvis as Chief Financial Officer enhances commercial readiness
Chief Innovation Officer Professor Vipul Bansal awarded Distinguished Professorship
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Nexsen (ASX:NXN)
OPEN ARTICLE